Meritage Portfolio Management’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-141,485
Closed -$10.1M 351
2023
Q4
$10.1M Buy
141,485
+8,806
+7% +$613K 0.67% 34
2023
Q3
$9.21M Sell
132,679
-1,302
-1% -$98.4K 0.68% 31
2023
Q2
$10.8M Sell
133,981
-6,485
-5% -$530K 0.77% 25
2023
Q1
$11.3M Buy
140,466
+58,853
+72% +$4.74M 0.85% 25
2022
Q4
$6.11M Sell
81,613
-3,824
-4% -$272K 0.48% 71
2022
Q3
$5.51M Sell
85,437
-1,205
-1% -$83.5K 0.46% 65
2022
Q2
$6M Sell
86,642
-4,160
-5% -$309K 0.47% 68
2022
Q1
$6.97M Sell
90,802
-1,915
-2% -$138K 0.43% 70
2021
Q4
$7.1M Sell
92,717
-858
-0.9% -$63.1K 0.4% 69
2021
Q3
$6.91M Buy
93,575
+431
+0.5% +$32.3K 0.41% 61
2021
Q2
$6.21M Sell
93,144
-1,731
-2% -$116K 0.37% 75
2021
Q1
$7.06M Sell
94,875
-3,233
-3% -$245K 0.47% 59
2020
Q4
$7.14M Buy
98,108
+533
+0.5% +$37.6K 0.52% 53
2020
Q3
$6.49M Buy
+97,575
New +$6.18M 0.58% 48

Other funds holding HOLX

Meritage Portfolio Management's HOLX Position: Q1 2024 in Review

Meritage Portfolio Management sold out of Hologic (HOLX) in Q1 2024, closing a stake of 141,485 shares — an estimated $10.1M sold.

Meritage Portfolio Management first reported a position in HOLX in Q3 2020 and held it in 14 quarters. The position peaked at $11.3M in Q1 2023. 706 funds tracked by Wall St. Rank hold HOLX as of Q1 2024.

  • Meritage Portfolio Management reported no remaining Hologic position as of Q1 2024 after selling out during the quarter.
  • Meritage Portfolio Management sold 141,485 Hologic shares in Q1 2024, an estimated $10.1M.
  • Meritage Portfolio Management first reported a position in Hologic in Q3 2020 and held it in 14 quarters.
  • Meritage Portfolio Management's Hologic position peaked at $11.3M in Q1 2023.
  • 706 funds tracked by Wall St. Rank held Hologic as of Q1 2024.

Based on Meritage Portfolio Management's 13F filing for Q1 2024, filed 29 Apr 2024.